Clinical trial
Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And…
NCT00463762 · Pfizer, Industry · Withdrawn
Key facts
| NCT number | NCT00463762 |
|---|---|
| Title | Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections. |
| Official title | Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections In Slovakia. An Open, Prospective, Non-Comparative Study. |
| Lead sponsor | Pfizer, Industry |
| Status | Withdrawn |
| Study type | Observational |
| Conditions | Abscess, Intra-Abdominal, Cholecystitis, Wound Infections, Peritonitis, Appendicitis |
| Intervention type | Drug |
| Interventions | CP-75385-02 Cefoperazone/sulbactam |
| Enrollment | 0 |
| Start date | May 1, 2007 |
| First posted | Apr 20, 2007 |
| Last update posted | Apr 22, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: